Health Care
Commentary
The Feds Continue to Fail Their Covid-19 Test
Americans who have COVID-19 but lack symptoms should only isolate for five days, according to new guidance issued by the Centers for Disease Control and Prevention last week. That’s a significant improvement over the agency’s previous recommendation of 10 days. The revised guidelines have sparked fierce debate because the CDC included no directive that ...
Commentary
What cereal can teach us about the generic drug market
Imagine you’re walking the aisles of your local supermarket, on the hunt for your favorite cereal. You usually purchase the generic version, since it tastes nearly the same and is much cheaper than the name-brand version. But today, you notice that the price of the name-brand cereal is just a ...
Commentary
Democrats Stumble Over Their Shady BBB Gimmicks
Last week, on Dec. 19 specifically, Sen. Joe Manchin, D-W.Va., announced that he would not support the current iteration of the Build Back Better Act. His decision calls the future of the $1.75 trillion spending package into serious question. For this, Democrats have only themselves to blame. After all, Manchin’s demands ...
Commentary
The FDA needs reform. Biden’s nominee is not the person to do it
By Henry I. Miller, M.S., M.D. and Jeff Stier When President Joe Biden nominated Obama-era Food and Drug Administration Commissioner Dr. Robert Califf to return to his old post, he made what is widely seen as a safe, if uninspired, choice. Califf is a distinguished cardiologist and clinical trial specialist, ...
Commentary
Expanding telehealth access is a lifesaver for vulnerable patients
It’s hard to find a silver lining in a pandemic. But COVID-19 has convinced the medical and policymaking establishments, perhaps unwittingly, that high-quality care can be delivered remotely. The telehealth revolution is upon us. Lawmakers waived numerous arcane and outdated regulations governing the use of telemedicine to make the service ...
Commentary
A Disastrous Year In Federal Healthcare Spending
For current and future taxpayers, 2021 was a brutal year—at least when it comes to healthcare spending. Congress and the Biden administration approved tens of billions in new expenditures. Much of that money was, or will be, wasted on inefficient programs and subsidies that do little to improve the quality ...
Commentary
Build Back Better’s bad healthcare provisions
With Sen. Joe Manchin saying he won’t vote for the Build Back Better Act, at least in the bill’s current form, Democrats are scrambling to revise the bill. Patients and taxpayers can only hope they fail. The bill is packed with disastrous healthcare policies. For instance, Build Back Better would ...
Commentary
The Biden administration should make promising anti-viral medications widely available to as many Americans as possible.
By Henry I. Miller, M.S., M.D. and John J. Cohrssen Earlier this week, President Biden outlined new steps to confront the growing spread of Covid-19 from the new, more infectious Omicron variant, which, in only a few weeks, has soared from virtually nonexistent to 73 percent of all new cases. ...
Commentary
Despite What the White House Says, Obamacare Is Deeply Troubled
Open enrollment on Obamacare’s health insurance exchanges is in full swing. Consumers in most states, including the 33 that use the federally operated HealthCare.gov, have until Jan. 15 to sign up for coverage for 2022. The Biden administration says things have never been better, and that premiums are declining, more insurers ...
Commentary
Building Back To Canadian Health Care?
Senate Democrats have delayed action on their multi-trillion-dollar Build Back Better Act until the New Year. If it passes, even more people will be dependent on the federal government for health coverage. It would represent the latest stepping-stone toward single-payer health care, which progressives like Senator Bernie Sanders, I-Vt., have dreamed of ...
The Feds Continue to Fail Their Covid-19 Test
Americans who have COVID-19 but lack symptoms should only isolate for five days, according to new guidance issued by the Centers for Disease Control and Prevention last week. That’s a significant improvement over the agency’s previous recommendation of 10 days. The revised guidelines have sparked fierce debate because the CDC included no directive that ...
What cereal can teach us about the generic drug market
Imagine you’re walking the aisles of your local supermarket, on the hunt for your favorite cereal. You usually purchase the generic version, since it tastes nearly the same and is much cheaper than the name-brand version. But today, you notice that the price of the name-brand cereal is just a ...
Democrats Stumble Over Their Shady BBB Gimmicks
Last week, on Dec. 19 specifically, Sen. Joe Manchin, D-W.Va., announced that he would not support the current iteration of the Build Back Better Act. His decision calls the future of the $1.75 trillion spending package into serious question. For this, Democrats have only themselves to blame. After all, Manchin’s demands ...
The FDA needs reform. Biden’s nominee is not the person to do it
By Henry I. Miller, M.S., M.D. and Jeff Stier When President Joe Biden nominated Obama-era Food and Drug Administration Commissioner Dr. Robert Califf to return to his old post, he made what is widely seen as a safe, if uninspired, choice. Califf is a distinguished cardiologist and clinical trial specialist, ...
Expanding telehealth access is a lifesaver for vulnerable patients
It’s hard to find a silver lining in a pandemic. But COVID-19 has convinced the medical and policymaking establishments, perhaps unwittingly, that high-quality care can be delivered remotely. The telehealth revolution is upon us. Lawmakers waived numerous arcane and outdated regulations governing the use of telemedicine to make the service ...
A Disastrous Year In Federal Healthcare Spending
For current and future taxpayers, 2021 was a brutal year—at least when it comes to healthcare spending. Congress and the Biden administration approved tens of billions in new expenditures. Much of that money was, or will be, wasted on inefficient programs and subsidies that do little to improve the quality ...
Build Back Better’s bad healthcare provisions
With Sen. Joe Manchin saying he won’t vote for the Build Back Better Act, at least in the bill’s current form, Democrats are scrambling to revise the bill. Patients and taxpayers can only hope they fail. The bill is packed with disastrous healthcare policies. For instance, Build Back Better would ...
The Biden administration should make promising anti-viral medications widely available to as many Americans as possible.
By Henry I. Miller, M.S., M.D. and John J. Cohrssen Earlier this week, President Biden outlined new steps to confront the growing spread of Covid-19 from the new, more infectious Omicron variant, which, in only a few weeks, has soared from virtually nonexistent to 73 percent of all new cases. ...
Despite What the White House Says, Obamacare Is Deeply Troubled
Open enrollment on Obamacare’s health insurance exchanges is in full swing. Consumers in most states, including the 33 that use the federally operated HealthCare.gov, have until Jan. 15 to sign up for coverage for 2022. The Biden administration says things have never been better, and that premiums are declining, more insurers ...
Building Back To Canadian Health Care?
Senate Democrats have delayed action on their multi-trillion-dollar Build Back Better Act until the New Year. If it passes, even more people will be dependent on the federal government for health coverage. It would represent the latest stepping-stone toward single-payer health care, which progressives like Senator Bernie Sanders, I-Vt., have dreamed of ...
